Skye Bioscience Stock Forecast

SKYE's stock price has decreased by -87.24% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Skye Bioscience stock have an average target of 16.6, with a low estimate of 14 and a high estimate of 20. The average target predicts an increase of 827.37% from the current stock price of 1.79.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$14	$16.6	$15	$20
Change	+682.12%	+827.37%	+737.99%	+1017.3%

* Price targets were last updated on Mar 21, 2025.

Analyst Ratings

The average analyst rating for Skye Bioscience stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	1	1	1	1	1	1
Buy	5	5	5	6	6	5
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	7	7	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Albert Lowe Craig-Hallum	Craig-Hallum	Strong Buy Maintains $18 → $14	Strong Buy	Maintains	$18 → $14	+682.12%	Mar 21, 2025
Jonathan Wolleben Citizens Capital Markets	Citizens Capital Markets	Buy Reiterates $15	Buy	Reiterates	$15	+737.99%	Mar 21, 2025
Andy Hsieh William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Feb 28, 2025
George Farmer Scotiabank	Scotiabank	Buy Initiates $20	Buy	Initiates	$20	+1,017.32%	Sep 30, 2024
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Reiterates $20	Buy	Reiterates	$20	+1,017.32%	Sep 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 3.67M

Revenue Next Year

n/a

EPS This Year

-1.22

from -0.73

EPS Next Year

-1.40

from -1.22

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	-	-	3.67M
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-7.46	-5.24	-8.77	-5.37	-0.73	-1.22	-1.40	-1.82
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	9	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.05	-1.11	-1.44
Avg	-1.22	-1.40	-1.82
Low	-1.34	-1.68	-2.27

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.